340 related articles for article (PubMed ID: 21772815)
41. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
42. The nature of tremor circuits in parkinsonian and essential tremor.
Cagnan H; Little S; Foltynie T; Limousin P; Zrinzo L; Hariz M; Cheeran B; Fitzgerald J; Green AL; Aziz T; Brown P
Brain; 2014 Dec; 137(Pt 12):3223-34. PubMed ID: 25200741
[TBL] [Abstract][Full Text] [Related]
43. Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison.
Herrera-Meza G; Manzo J; Hernández ME; Miquel M; García LI
Neurologia; 2014 Sep; 29(7):416-22. PubMed ID: 24332783
[TBL] [Abstract][Full Text] [Related]
44. [Successful treatment with bilateral deep brain stimulation of the subthalamic nucleus for benign tremulous parkinsonism].
Fukae J; Fukaya C; Oshima H; Ishii K; Tsuboi Y; Katayama Y; Hattori N
Rinsho Shinkeigaku; 2014; 54(6):511-4. PubMed ID: 24990837
[TBL] [Abstract][Full Text] [Related]
45. Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements.
Cousins MS; Atherton A; Salamone JD
Physiol Behav; 1998 May; 64(2):153-8. PubMed ID: 9662079
[TBL] [Abstract][Full Text] [Related]
46. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
Collins LE; Sager TN; Sams AG; Pennarola A; Port RG; Shahriari M; Salamone JD
Pharmacol Biochem Behav; 2012 Jan; 100(3):498-505. PubMed ID: 22037410
[TBL] [Abstract][Full Text] [Related]
47. Effects of cabergoline and rotigotine on tacrine-induced tremulous jaw movements in rats.
Koganemaru G; Abe H; Kuramashi A; Ebihara K; Matsuo H; Funahashi H; Yasuda K; Ikeda T; Nishimori T; Ishida Y
Pharmacol Biochem Behav; 2014 Nov; 126():103-8. PubMed ID: 25265240
[TBL] [Abstract][Full Text] [Related]
48. Deep brain stimulation for levodopa-refractory benign tremulous parkinsonism.
Konno T; Ross OA; Wharen RE; Uitti RJ; Wszolek ZK
Neurol Neurochir Pol; 2016; 50(5):383-6. PubMed ID: 27591066
[TBL] [Abstract][Full Text] [Related]
49. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
Mayorga AJ; Cousins MS; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Eur J Pharmacol; 1999 Jan; 364(1):7-11. PubMed ID: 9920179
[TBL] [Abstract][Full Text] [Related]
51. Paradoxical aspects of parkinsonian tremor.
Fishman PS
Mov Disord; 2008 Jan; 23(2):168-73. PubMed ID: 17973325
[TBL] [Abstract][Full Text] [Related]
52. Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.
Finn M; Mayorga AJ; Conlan A; Salamone JD
Neuroscience; 1997 Sep; 80(2):535-44. PubMed ID: 9284355
[TBL] [Abstract][Full Text] [Related]
53. Benign tremulous parkinsonism.
Josephs KA; Matsumoto JY; Ahlskog JE
Arch Neurol; 2006 Mar; 63(3):354-7. PubMed ID: 16533962
[TBL] [Abstract][Full Text] [Related]
54. Aged monkeys as a partial model for Parkinson's disease.
Hurley PJ; Elsworth JD; Whittaker MC; Roth RH; Redmond DE
Pharmacol Biochem Behav; 2011 Sep; 99(3):324-32. PubMed ID: 21620883
[TBL] [Abstract][Full Text] [Related]
55. Jaw tremor: a manifestation of vascular parkinsonism? - a case report.
Udagedara TB; Gooneratne IK
BMC Neurol; 2018 Jun; 18(1):92. PubMed ID: 29960586
[TBL] [Abstract][Full Text] [Related]
56. Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.
Shaikh AG
Neurol Sci; 2017 May; 38(5):855-863. PubMed ID: 28229302
[TBL] [Abstract][Full Text] [Related]
57. [Parkinsonian tremor, rigidity and flapping tremor].
Kuno S
Nihon Rinsho; 1993 Nov; 51(11):2823-8. PubMed ID: 8277556
[TBL] [Abstract][Full Text] [Related]
58. Parkinsonian symptoms in tardive dyskinesia. A prevalence study.
Myslobodsky MS; Holden T; Sandler R
S Afr Med J; 1986 Mar; 69(7):424-6. PubMed ID: 3961632
[TBL] [Abstract][Full Text] [Related]
59. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
[TBL] [Abstract][Full Text] [Related]
60. High-frequency oscillations (>200 Hz) in the human non-parkinsonian subthalamic nucleus.
Danish SF; Moyer JT; Finkel LH; Baltuch GH; Jaggi JL; Priori A; Foffani G
Brain Res Bull; 2007 Sep; 74(1-3):84-90. PubMed ID: 17683793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
